Xinhua Li

Xinhua Li's work experience includes serving as the Executive Vice President of Drug Development at Clear Scientific, Inc since March 2019. Prior to this role, Li worked as the Executive Vice President of Chemistry at Nano Terra, Inc from January 2009 to March 2019. Before that, Li held the position of Vice President of Chemistry at Arsenal Medical from 2006 to 2008. Li also worked as a Principal Scientist at Genzyme/Geltex from 1999 to 2006 and as a Senior Scientist at Dyax Corporation from 1996 to 1999.

Xinhua Li has a diverse education history. They obtained their Ph.D. in Chemistry from Washington University in St. Louis between the years 1989 and 1994. Following this, Xinhua Li pursued a post-doctorate in Chemistry at Harvard University from 1994 to 1996. They further expanded their academic qualifications by pursuing an MBA degree specialized in Managing Innovation at Babson F.W. Olin Graduate School of Business, from 1999 to 2004. Xinhua Li also has experience studying at Harvard University, although the specific details such as the field of study and degree name are not provided.